INNOVATION IN CNS EXPERIMENTAL MEDICINE
P1vital is pleased to offer links to these external sites (hover over names for more detail):
Please note that these are third party external sites and P1vital takes no responsibility for the accuracy and reliability of their content.
Professor Bill Deakin Department of Psychiatry, University of Manchester
Bill Deakin has been Professor of Psychiatry at the University of Manchester since 1990. His research interests are in developing new treatments for depression and schizophrenia based on imaging and other investigations of normal and pathological neurotransmitter function, particularly of the serotonin and glutamate systems in humans.
Professor Nick Girdler School of Dentistry, University of Newcastle upon Tyne
Nick Girdler is Professor of Sedation Dentistry at the University of Newcastle upon Tyne. His research interests are in sedation dentistry and the treatment of anxiety disorders in patients with dental phobia.
Professor Guy Goodwin Department of Psychiatry, University of Oxford
Guy Goodwin has been W A Handley Professor of Psychiatry at the University of Oxford since 1996. His research interests are in the treatment of bipolar disorder and the application of neuroscience in understanding the neurobiology of mood disorder and developing new treatments.
Dr Catherine Harmer, Department of Psychiatry, University of Oxford
Catherine Harmer is a Reader in Psychology and Head of the Psychopharmacology and Emotion Research laboratory at the University Department of Psychiatry in Oxford. Her interests focus on the neuropsychology of antidepressant and anxiolytic drug action and in the development of early biomarker tests of drug efficacy.
Professor Robin G Morris Clinical Neuropsychology, King's College Hospital, London
Robin Morris is a consultant neuropsychologist at King’s College Hospital, where he is head of the Clinical Neuropsychology Department. His main interests are in the neuropsychology of memory and also of executive functioning. He has conducted research on a range of patients with neuropsychological disorder, including those with focal brain damage, schizophrenia, and Alzheimer’s disease.
Professor David Nutt Neuropsychopharmacology, Imperial College London
David Nutt is The Edmond J Safra Chair in Neuropsychopharmacology at Imperial College London. His research interests are in the psychopharmacology of anxiety, addiction and insomnia.
Professor John Wilding Department of Medicine, University of Liverpool
John Wilding is Professor of Medicine at the University of Liverpool's Aintree hospital His research interests are in the clinical management of obesity and diabetes, the neurobiology of obesity and the development of new treatments for obesity and metabolic disorders.
Professor Lawrence Wilkinson Department of Medicine & School of Psychology, Cardiff University
Lawrence Wilkinson is Professor of Behavioural Genetics and Head of the Behavioural Genetics Group at Cardiff University. His research interests include the study of gene variants influencing impulsive behaviours, the familial dementias, imprinted gene effects on behaviour and the translation of pre-clinical models into a better understanding of psychopathology in people
Professor Steve Williams Department of Imaging Sciences, Institute of Psychiatry
Steve Williams is Professor of Imaging Sciences and Head of the Centre for Neuroimaging Sciences at the Institute of Psychiatry, King’s College London. His research interests include the development of novel imaging methods for visualising CNS disorders and the translation of imaging methods from pre-clinical observations to the clinic.
Kissileff Laboratory for the Study of Human Ingestive Behaviour, School of Psychology,
University of Liverpool.
The Kissileff Laboratory is a purpose built suite of rooms designed for the experimental study of human eating, the expression of appetite and the development of eating disorders. Professor Steve Cooper and Dr Jason Halford are the Co-directors of the Laboratory.
M2M Regulatory Consultants LtdM2M Regulatory Consultants Ltd offer the following bespoke services to the Pharma/Biotech sector. The Principal is David Priestley, MSc CChem MRCS.
P1vital, the P1vital logo and all other P1vital product or service namesare trade marks of P1vital Limited. © P1vital Limited. All rights reserved.